MILI 6235 is also offered in Spring 2025
MILI 6235 is also offered in Spring 2024
MILI 6235 is also offered in Spring 2023
MILI 6235 is also offered in Spring 2022
Spring 2025 | MILI 6235 Section 070: Pharmaceutical Industry: Business and Policy (56686)
- Instructor(s)
- No instructor assigned
- Class Component:
- Lecture
- Credits:
- 2 Credits
- Grading Basis:
- A-F only
- Instructor Consent:
- No Special Consent Required
- Instruction Mode:
- Completely Online
- Class Attributes:
Online Course
- Enrollment Requirements:
- MBA or Mgmt Science MBA
- Times and Locations:
Second Half of Term
Off Campus
Virtual Rooms ONLINEONLY
- Enrollment Status:
Open (0 of 48 seats filled)
- Also Offered:
- Course Catalog Description:
- Business/policy issues specific to pharmaceutical industry. Interdisciplinary perspectives, active involvement by industry leaders.
- Class Notes:
- Class combines asynchronous content during second half of semester and synchronous remote meetings from 8 am-12 pm on 3/16, 4/6, and 4/27. Students must attend live remote sessions on these dates.
- Class Description:
The development, manufacturing, distribution, economic evaluation, purchasing, utilization management, and ordering of pharmaceuticals is a large and growing portion of the health sector with unique market characteristics, complex regulatory processes, rapid technological change, high expense growth, and vigorously-debated public policy issues. The pharmaceutical industry in Minnesota is growing and dynamic. Boundaries between pharmaceuticals, medical devices and biotechnology are blurring. This course is a joint venture of the Carlson School of Management and the College of Pharmacy at the University of Minnesota.
In addition to academic faculty from these schools, the course also engages the participation of key leaders in the pharmaceutical industry and the health sector in general. The panel format, followed by receptions during which students can meet panelists, facilitates opportunities for interaction among guest faculty and students. Executives from the following organizations have participated and/or are being invited to participate: Chronimed, CIMA Labs, Express Scripts, Medtronic, Orphan Medical, Paddock Laboratories, Pfizer Corp., Prime Therapeutics, RxHub, Upsher-Smith Laboratories, 3M Pharmaceuticals, Algos Therapeutics, Bel-Aire Pharmacy, Carlson School of Management, College of Pharmacy, Fairview Health Services, HealthEast, Klepinski & Duval, PiperJaffray, the VHA.
- Who Should Take This Class?:
- This course is designed to engage full-time and working professional students in the fields of management and pharmacy though interdisciplinary exposure to key business and policy aspects of the pharmaceutical industry. For general management students, it provides exposure to the technical, clinical and policy issues of the pharmaceutical industry. For pharmacy students, it provides additional exposure to the business, financial, and entrepreneurial aspects of the pharmaceutical industry. For all, it provides an excellent opportunity for interdisciplinary learning and networking. This course is reserved for MBA students. If you are a non-MBA student seeking to take this course, fill out the petition form found at goo.gl/9Y9PR5. Additional information, including petition deadlines, can be found at http://carlsonschool.umn.edu/degrees/master-business-administration/part-time-mba/admissions/mba-course-petition-form
- Learning Objectives:
- Students successfully completing this course should: (1) have a thorough understanding of key policy, management, and regulatory issues affecting the pharmaceutical industry, including understanding the perspectives of manufacturers, health plans, consumers, and policy makers, and be able to make a case for either side of these issues; (2) understand the factors driving valuation in the pharmaceutical industry and be able to assess market valuation of for-profit firms and mergers among firms; and (3) and be able to critically assess growth projections for new and established drugs. The overall objective of this course is to help prepare future leaders across the spectrum of pharmaceutical development, investment, manufacturing, distribution, utilization management, and ordering.
- Textbooks:
- https://bookstores.umn.edu/course-lookup/56686/1253
- Instructor Supplied Information Last Updated:
- 8 February 2017
ClassInfo Links - Spring 2025 Medical Industry Leadrshp Inst Classes